Dr. Birtcher reviewed the interrelationship between diabetes, glycemic control, and cardiovascular disease. She also discussed the new and emerging cardiovascular outcome trial (CVOT) data for glucose lowering therapies and elucidated the proposed pleiotropic cardiovascular effects of these therapies in patients with type 2 diabetes (T2D). Dr. Birtcher also translated the CVOT data to direct patient care and the potential implications for overall T2D management strategies in patients with and without cardiovascular disease.
For an updated presentation by Dr. Bircher, please check the file below:
Birtcher.CEC CVOT Grand Rounds Slide Deck.Hackensack NJ.4.25.19.pdf